US4022206A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Vaccine delivery system
Assignee: Merck and Co Inc
•
Filing: 1975-08-01
•
Granted: 1977-05-10
•
Expires: 1995-08-01
Abstract
Abstract Vaccine delivery system having a lyophilized vaccine in human dosage concentration loaded into presterilized single dosage syringe having a squeezable body portion and a separate package containing enough water for injection to reconstitute the single dose of lyophilized vaccine.
Inventors
- 👤 Maurice R. Hilleman
- 👤 William J. McAleer
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-25 09:07
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/178; A61M5/28; A61M5/281; A61M5/282; A61M5/285; A61M5/288
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
133 words
A vaccine delivery system suitable for human administration comprising a hypodermic syringe having a single dosage container portion made of a plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending from the plastic container portion to convey fluids from within the container out through the tip of the needle when the needle is inserted under the skin and the container is squeezed, a vaccine in an amount suitable for human administration sealed within the container, the vaccine being in the lyophilized state, whereby the vaccine is preserved for storage and shipment and the syringe is protected from leakage during storage and shipment, and a separate container of a single dose of water for injection to reconstitute the lyophilized vaccine in the hypodermic syringe.
Claim 2
Dependent Claim
133 words
A vaccine delivery system suitable for human administration comprising a hypodermic syringe having a single dosage container portion made of a plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending from the plastic container portion to convey fluids from within the container out through the tip of the needle when the needle is inserted under the skin and the container is squeezed, a vaccine in an amount suitable for human administration sealed within the container, the vaccine being in the lyophilized state, whereby the vaccine is preserved for storage and shipment and the syringe is protected from leakage during storage and shipment, and a separate container of a single dose of water for injection to reconstitute the lyophilized vaccine in the hypodermic syringe.
Claim 3
Dependent Claim
20 words
A vaccine delivery system according to claim 1 wherein said vaccine is at a temperature of below about 8° C.
Claim 4
Dependent Claim
18 words
A vaccine delivery system according to claim 1 wherein said container portion is composed of low density polyethylene.
Claim 5
Dependent Claim
22 words
A vaccine delivery system according to claim 1 wherein the container for the water for injection is formed of low density polyethylene.
Claim 6
Dependent Claim
23 words
A vaccine delivery system according to claim 1 wherein the container for the water for injection is formed of a vinyl blister pack.
Claim 7
Dependent Claim
20 words
A vaccine delivery system according to claim 1 wherein the container for the water for injection is formed of polypropylene.
Claim 8
Dependent Claim
78 words
In combination, a plurality of single dosage hypodermic syringes each comprising a tubular container portion of plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending out from the container portion, a single dosage of a lyophilized vaccine suitable for human administration contained in each tubular container portion and sealed therein, and a gas, moisture and light impervious bag enveloping the plurality of syringes and sealing the syringes therein.
Claim 9
Dependent Claim
78 words
In combination, a plurality of single dosage hypodermic syringes each comprising a tubular container portion of plastic material which is resiliently flexible at room temperature and a needle portion comprising a hollow sharp needle extending out from the container portion, a single dosage of a lyophilized vaccine suitable for human administration contained in each tubular container portion and sealed therein, and a gas, moisture and light impervious bag enveloping the plurality of syringes and sealing the syringes therein.
Claim 10
Dependent Claim
18 words
A combination according to claim 7 wherein the gas, moisture and light impervious bag is of aluminum foil.
Claim 11
Dependent Claim
21 words
A combination according to claim 7 wherein the syringes include removable dust covers enveloping the outer end of their needle portion.
Claim 12
Independent Claim
66 words
A method of preparing vaccine for delivery storage and administration comprising the steps of filling a plurality of single dosage, tubular, flexible, hypodermic syringes with an aqueous vaccine diluted to human administration concentrations, freezing the vaccine, lyophilizing the vaccine, sealing the syringes closed under anhydrous conditions, and enveloping and sealing a plurality of the filled and sealed syringes inside a gas, moisture and light impervious bag.
Claim 13
Independent Claim
66 words
A method of preparing vaccine for delivery storage and administration comprising the steps of filling a plurality of single dosage, tubular, flexible, hypodermic syringes with an aqueous vaccine diluted to human administration concentrations, freezing the vaccine, lyophilizing the vaccine, sealing the syringes closed under anhydrous conditions, and enveloping and sealing a plurality of the filled and sealed syringes inside a gas, moisture and light impervious bag.
Claim 14
Dependent Claim
22 words
A method according to claim 10 further including the step of subjecting the syringe to an ethylene oxide atmosphere prior to filling.
Claim 15
Dependent Claim
24 words
A method according to claim 11 further including the step of subjecting the syringe to a vaccum to purge the syringe of ethylene oxide.
References Cited (Backward Citations)
US2726656A
Cited
US2895475A
Cited
US3158283A
Cited
US3325059A
Cited
US3337041A
Cited
US3286832A
Cited
US3472369A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1980-05-09 | 1980-11-08 | 1981-05-10 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1984-05-09 | 1984-11-08 | 1985-05-10 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1988-05-09 | 1988-11-08 | 1989-05-10 | $7700.00 | Window Closed / Lapsed |